Adcock Ingram reported a double-digit increase in full-year earnings and dividends even as the seller of brands such as Corenza C and Panado navigated a weak economy that saw consumers coming under increasing pressure.
Drug maker Adcock Ingram has reported a double-digit increase in full-year earnings and dividends even as the seller of brands such as Corenza C and Panado navigated a weak economy that saw consumers coming under increasing pressure.
It described its results as a"healthy financial and operational performance" amid a weak economy characterised by currency weakness and volatility. It also noted that SA's cash-strapped consumers had also been constrained during the period.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Spur posts triple-digit dividend on blackout-led restaurant rushThe group plans to open 53 new stores in FY2024, with a targeted focus on rolling out smaller format stores in local towns.
Read more »
Curro profit jumps after fee hikes, stricter payment 'discipline'Curro managed to deliver double-digit interim earnings and turnover growth even with relatively modest student enrolment increases.
Read more »
Curro profit jumps after fee hikes, stricter payment 'discipline'Curro managed to deliver double-digit interim earnings and turnover growth even with relatively modest student enrolment increases.
Read more »
BHP’s full-year profit falls 37% as China’s metals demand wanesBHP’s plunging earnings mirror those posted by iron ore rival Rio Tinto Group last month.
Read more »